TAKADA Takuma
Department Research Institutes and Facilities, Research Institutes and Facilities Position Assistant Professor |
|
Language | English |
Title | Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2 |
Conference | 第87回日本循環器学会学術集会 |
Conference Type | Nationwide Conferences |
Presentation Type | Speech |
Lecture Type | General |
Publisher and common publisher | Nobutaka Ikeda, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Yohei Kobayashi, Satoshi Ikeda, Kite Kim, Toru Takase, Shuhei Tsuji, Maki Ohi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Yoshito Ogihara, Yugo Yamashita |
Date | 2023/03/10 |
Venue (city and name of the country) |
福岡 |
Summary | Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening complication after acute pulmonary embolism (PE). The incidence has not been fully evaluated in the era of direct oral anticoagulants (DOACs). Methods: The COMMAND VTE Registry-2 is a multicenter registry enrolling 5197 consecutive acute symptomatic venous thromboembolism patients among 31 centers in Japan. From the database, the incidence of CTEPH was ascertained. COMMAND-CTEPH Risk Score was created based on the results of Cox regression analysis to stratify the risk of development of CTEPH. Results: After a median 747-days follow-up of 2787 acute-PE patients, 48 CTEPH were identified (cumulative incidence 2.4%). There was no significant difference in the incidence of CTEPH between maintenance treatments of DOACs (2.3%) and warfarin (3.7%). Of the acute-PE patients with a Command-CTEPH Risk Score of 4 (maximum), 35.3% developed CTEPH. Conclusions: The cumulative incidence of CTEPH after acute-PE in the DOACs era was 2.4%. Stratification of risk of developing CTEPH may be useful for follow-up of PE. |